Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
International Journal of Radiation Biology|November 23, 2006
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapyJames L Tatum, Gary J Kelloff, Robert J Gillies, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
European Radiology|March 14, 2026
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working GroupAdriano B Dias, Jelle Barentsz, Clare Allen, et al.
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
BMC Cancer|October 23, 2016
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerEdward Johnston, Hayley Pye, Elisenda Bonet-Carne, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
Pageof 32